Allergy 24-hr
Product Images NDC 64679-982

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Allergy 24-hr (NDC 64679-982). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Wockhardt Usa Llc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Blister (Fexofenhivesotc Figure 01)

This text appears to be information about Children’s Fexofenadine HCI Tablet, USP in 30mg strength for 12-hour relief of HIVES. The tablets are distributed by Wockhardt USA LLC based in Parsippany, NJ, USA. The product has a specific National Drug Code (NDC) listed as 64679-744-06. The text also mentions lot and expiration date information.*

FDA Label Image

Carton (Fexofenhivesotc Figure 02)

This is a product description for Fexofenadine HCI Tablets, USP 30 mg. It is an antihistamine used for the relief of itching due to hives. The drug should not be taken as a substitute for epinephrine in cases of severe allergy symptoms. The directions for use vary by age group, with specific dosages outlined for adults, children, and elderly patients. It also includes warnings, precautions, and a list of inactive ingredients. For more information or questions, consumers can contact the toll-free number provided.*

FDA Label Image

Blister (Fexofenhivesotc Figure 03)

This text appears to be a label for Fexofenadine HCI tablets, USP, with a dosage of 60 mg to be taken every 12 hours for the treatment of HIVES. The tablets are distributed by Wockhardt USA LLC, located in Parsippany, NJ 07054, USA. The lot expiration date is provided but not clearly readable.*

FDA Label Image

Carton (Fexofenhivesotc Figure 04)

This text provides important drug facts for Fexofenadine HCI 60 mg tablets, which is an antihistamine used for the relief of itching due to hives. It includes information on the active ingredient, warnings for severe allergic reactions, precautions for usage in certain conditions, dosage instructions, and directions for safe use. Additionally, it lists inactive ingredients and contact information for questions or comments. The product is suitable for adults and children over 12 years old, with specific guidance for those with kidney disease or who are pregnant or breastfeeding.*

FDA Label Image

Blister (Fexofenhivesotc Figure 05)

This is a label for Fexofenadine HCI tablets, USP at a dosage of 180 mg for 24-hour symptom relief of HIVES. The tablets are distributed by Wockhardt USA LLC, located in Parsippany, NJ 07054, USA. The product includes information on lot numbers and expiration dates for quality control and tracking purposes.*

FDA Label Image

Carton (Fexofenhivesotc Figure 06)

The text contains information about Fexofenadine HCI 180mg tablets, an antihistamine used to reduce hives and itching due to hives. It also provides warnings, directions for use, inactive ingredients, and contact information for questions or comments. The product is indicated for adults and children over 12 years old, with specific guidance for those with kidney disease and the elderly. It emphasizes not using the tablets to prevent hives and advises seeking medical help in case of allergic reactions. The product should be stored at room temperature and protected from excessive moisture.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.